TICAGRELOR

Product NDC
42571-293
Requested package NDC
42571-293-11
11-digit product format
425710293
Labeler code
42571
Product ID
42571-293_58c2e103-8f0a-c4e1-e063-6294a90a2260
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
TICAGRELORE
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Micro Labs Limited
Application
ANDA208539
Marketing category
ANDA
Marketing start
2026-11-01
Substance
TICAGRELOR
Active strength
60 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A208539-001TICAGRELORTICAGRELOR60MGTABLET / ORALAB2026-04-27
A208539-002TICAGRELORTICAGRELOR90MGTABLET / ORALAB2026-04-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A208539-001AB
A208539-002AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A208539-001TICAGRELOR60MGTABLET / ORALAB2026-04-27d4dbc9d85df4…
2026-11-14 07:37:172026-10A208539-002TICAGRELOR90MGTABLET / ORALAB2026-04-27d4dbc9d85df4…
2026-10-15 13:18:302026-09A208539-001TICAGRELOR60MGTABLET / ORALAB2026-04-27c2088c7a36db…
2026-10-15 13:18:302026-09A208539-002TICAGRELOR90MGTABLET / ORALAB2026-04-27c2088c7a36db…
2026-09-14 22:38:342026-08A208539-001TICAGRELOR60MGTABLET / ORALAB2026-04-2784e616aacf4f…
2026-09-14 22:38:342026-08A208539-002TICAGRELOR90MGTABLET / ORALAB2026-04-2784e616aacf4f…
2026-08-18 06:07:402026-07A208539-001TICAGRELOR60MGTABLET / ORALAB2026-04-27caaa826d4ba7…
2026-08-18 06:07:402026-07A208539-002TICAGRELOR90MGTABLET / ORALAB2026-04-27caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208539-001TICAGRELOR60MGTABLET / ORALAB2026-04-27a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208539-002TICAGRELOR90MGTABLET / ORALAB2026-04-27a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A208539-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10A208539-002AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09A208539-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09A208539-002AB1c2088c7a36db…
2026-09-14 22:38:342026-08A208539-001AB184e616aacf4f…
2026-09-14 22:38:342026-08A208539-002AB184e616aacf4f…
2026-08-18 06:07:402026-07A208539-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07A208539-002AB1caaa826d4ba7…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208539-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208539-002AB1a50c72e98297…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
TICAGRELOR
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
TICAGRELOR60 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
GLH0314RVCInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1116635Internal RxNorm lookup
1666332Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2861af6a-7449-4686-bf0d-5f9c2db07631Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TICAGRELORTICAGRELORMicro Labs Limited2861af6a-7449-4686-bf0d-5f9c2db076312026-08-11Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 208539
application number: ANDA208539
ndc (package): 42571-293-11
ndc (product): 42571-293
ndc11 (package): 42571029311

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
42571-293-1142571029311100 TABLET, FILM COATED in 1 CARTON (42571-293-11) 2026-11-01NoNoCurrent